Alcohol metabolism in liver sinusoidal endothelial cells
Alcohol metabolism in liver sinusoidal endothelial cells
批准号:
8965570
负责人:
YASUKO IWAKIRI
金额:
$23.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2017-07-31
关键词:
AcetaldehydeAcetylationAlcohol abuseAlcohol consumptionAlcoholic Fatty LiverAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholsApoptosisBloodBlood VesselsCYP2E1 geneCell physiologyCellsChemicalsCirrhosisComplexCytochrome P-450 CYP2E1DataDevelopmentDietEarly InterventionEndothelial CellsEnzymesEthanolEthanol MetabolismFibrosisFunctional disorderGenesGoalsHeat-Shock Proteins 90HepatocyteIn VitroInjuryKnock-outKnockout MiceKupffer CellsLeadLiverLiver DysfunctionLiver diseasesMaintenanceMeasuresMediatingMetabolicMolecularMovementMusNitric OxideNitric Oxide SynthaseOxidative StressPharmaceutical PreparationsPrimary carcinoma of the liver cellsProductionProteinsReactive Oxygen SpeciesRegulationResearchRoleStructureTestingTissuesalcohol responsechronic alcohol ingestiondrug metabolismeffective therapyfeedinghuman NOS3 proteinin vivointrahepaticpreventprotein protein interactionpublic health relevanceresearch study
中文摘要
描述(申请人提供):肝窦内皮细胞(LSECs)保护肝脏,作为抵御来自肝窦血液的侮辱的第一道屏障。LSEC功能障碍与包括酒精性肝病在内的多种肝病的发生有关。细胞色素P450 2E1是酒精和药物代谢的关键酶。酒精诱导的细胞色素P450_2E_1产生代谢产物,如活性氧(ROS),从而导致组织损伤。肝脏中的细胞色素P450-2E1的研究主要集中在肝细胞上。在LSECs中,细胞色素P4502的存在和功能尚不清楚。我们最近发现,在LSECs中表达了细胞色素P450-2。这一发现很重要,因为它意味着LSEC介导的酒精代谢可能会产生损害正常内皮细胞功能的代谢物。本研究的目的是了解细胞色素P4502E1在酒精性肝损伤中的作用。功能障碍的LSECs的特征是窗孔丢失和一氧化氮(NO)产生减少。NO是肝内血管张力的关键调节因子。NO对维持LSEC的窗孔结构也是必不可少的,该结构允许蛋白质和其他物质在血管和肝细胞之间双向移动。长期饮酒可减少内皮型一氧化氮合酶(ENOS)衍生的一氧化氮的产生。此外,阻断NO的产生会增强乙醇诱导的肝损伤,这表明NO具有保护作用。饮酒降低eNOS活性和NO产生的机制尚不清楚。我们假设乙醇可诱导LSECs中细胞色素P4502的表达,进而减少内皮型一氧化氮合酶诱导的一氧化氮的产生。为了验证这些假说,我们将提出以下两个目标:1)确定乙醇对LSEC功能的作用;2)确定乙醇对LSECs中NO产生的依赖调节。鉴于除了酒精外,CYP2E1还代谢一系列药物和化学品,这项研究也将揭示LSEC在代谢这些物质方面的作用,这些物质最常见的归因于肝细胞。
英文摘要
DESCRIPTION (provided by applicant): Liver sinusoidal endothelial cells (LSECs) protect the liver, acting as the first barrier against insults coming from the sinusoidal blood. LSEC dysfunction is associated with the development of a wide range of liver diseases including alcohol liver disease. Cytochrome P450 2E1 (CYP2E1) is a key enzyme in alcohol and drug metabolism. Induction of CYP2E1 by alcohol generates metabolic products, such as reactive oxygen species (ROS), which cause tissue injury. The study of CYP2E1 in the liver has largely focused on hepatocytes. The presence and function of CYP2E1 in LSECs remains unknown. We recently found that CYP2E1 is expressed in LSECs. This finding is important, since it implies that LSEC-mediated metabolism of alcohol may generate metabolites that impair normal endothelial cell function. The goal of this study is to understand the role of CYP2E1 in LSECs in ethanol-induced liver injury. Dysfunctional LSECs are characterized by loss of fenestrae and decreased nitric oxide (NO) production. NO is a key regulator of intrahepatic vascular tone. NO is also essential for the maintenance of LSEC's fenestrae structure, which allows bi-directional movement of proteins and other substances between blood vessels and hepatocytes. Chronic alcohol consumption decreases endothelial NO synthase (eNOS)-derived NO production. Further, blocking NO production enhances ethanol-induced liver injury, suggesting NO's protective role. The mechanisms by which alcohol consumption diminishes eNOS activity and NO production are unknown. We hypothesize that ethanol induces CYP2E1 expression in LSECs and that induced CYP2E1 in turn decreases eNOS-derived NO production. To test these hypotheses, we will propose the following two aims: 1) Define the role of CYP2E1 in LSEC function in response to ethanol, and 2) Define CYP2E1-dependent regulation of NO production in LSECs in response to ethanol. Given that CYP2E1 metabolizes a wide range of drugs and chemicals besides alcohol, this study will also open the door to reveal LSEC's role in metabolizing those substances, which has most commonly been attributed to hepatocytes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hepatic lymphatics in alcohol-associated liver disease
-
批准号:10824029
-
项目类别:
-
资助金额:$21.16万
-
财政年份:2023
-
负责人:YASUKO IWAKIRI
-
依托单位:
Lymphatics in the liver
-
批准号:10391056
-
项目类别:
-
资助金额:$62.17万
-
财政年份:2022
-
负责人:YASUKO IWAKIRI
-
依托单位:
Lymphatics in the liver
-
批准号:10657334
-
项目类别:
-
资助金额:$58.93万
-
财政年份:2022
-
负责人:YASUKO IWAKIRI
-
依托单位:
Endotheliopathy and liver injury in COVID-19
-
批准号:10468220
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2021
-
负责人:YASUKO IWAKIRI
-
依托单位:
Endotheliopathy and liver injury in COVID-19
-
批准号:10662455
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2021
-
负责人:YASUKO IWAKIRI
-
依托单位:
Endotheliopathy and liver injury in COVID-19
-
批准号:10319358
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2021
-
负责人:YASUKO IWAKIRI
-
依托单位:
Hemodynamics and hepatic remodeling
-
批准号:9920142
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2018
-
负责人:YASUKO IWAKIRI
-
依托单位:
Hemodynamics and hepatic remodeling
-
批准号:9542958
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2018
-
负责人:YASUKO IWAKIRI
-
依托单位:
The role of Kupffer cells in alcohol-induced liver disease
-
批准号:9761401
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2017
-
负责人:YASUKO IWAKIRI
-
依托单位:
Mechanisms of Alcohol-Induced Hepatic Osteodystrophy
-
批准号:8969937
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2016
-
负责人:YASUKO IWAKIRI
-
依托单位:
Mechanisms of Alcohol-Induced Hepatic Osteodystrophy
-
批准号:9326892
-
项目类别:
-
资助金额:$19.89万
-
财政年份:2016
-
负责人:YASUKO IWAKIRI
-
依托单位:
Alcohol metabolism in liver sinusoidal endothelial cells
-
批准号:9116749
-
项目类别:
-
资助金额:$19.77万
-
财政年份:2015
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8286394
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8500246
-
项目类别:
-
资助金额:$34.05万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:7729752
-
项目类别:
-
资助金额:$38.64万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8587675
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8085781
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8724090
-
项目类别:
-
资助金额:$8.85万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8913298
-
项目类别:
-
资助金额:$6.1万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:7848984
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
海外基金